The development of resistance is a compelling reason for reviewing administration of
antibiotics. Recently, most Acinetobacter infections are caused by multidrug-resistant (MDR) …

Objectives: To describe the rates and patterns of colistin and tigecycline resistance among
Acinetobacter baumannii (A. baumannii) isolates from clinical specimens from 2 major …

Background & objectives: Treatment of serious life threatening infections due to multi-drug
resistant pathogens presents a difficult challenge due to the limited therapeutic options …

Objectives New antibacterial agents are required for the treatment of infections caused by
multidrug-resistant (MDR) Acinetobacter spp. Whether tigecycline constitutes an effective …

Sir, Navon-Venezia et al. 1 recently reported high tigecycline resistance in multidrug-
resistant Acinetobacter baumannii. The activity of tigecycline against A. baumannii was …

Objectives To compare the tigecycline activity profile against Acinetobacter spp. by Etest
versus broth microdilution in isolates with high Etest MIC. Methods Acinetobacter spp …

Because of its remarkable ability to acquire antibiotic resistance and to survive in
nosocomial environments, Acinetobacter baumannii has become a significant nosocomial …

Aim To evaluate the MIC values of tigecycline against carbapenem resistant Escherichia coli
and Klebsiella pneumoniae isolates. Materials and Methods This prospective study was …

In vitro activity of tigecycline against 148 strains of Acinetobacter baumannii isolated from
different patients hospitalized at Siriraj Hospital, Bangkok, Thailand during 2002 to 2005 …

Acinetobacter baumannii has emerged worldwide as an important nosocomial and
opportunistic pathogen, particularly in intensive care units (7). Treatment is difficult due to …